Conference Coverage

Treatment Trends in Stage 3 Prostate Cancer in VA vs Academic Centers

Abstract 47: 2016 AVAHO Meeting


 

Background: Prostate cancer is the second leading cause of cancer death in American men, diagnosed mainly in older men. Treatment options for stage 3 prostate cancer include external beam radiation plus hormone therapy (HT) vs external beam radiation plus brachytherapy vs radical prostatectomy in selected cases.

Methodology: A total of 52,384 patients with stage 3 prostate cancer have been studied from national cancer database comparing Veterans Affairs Hospital (VAH) vs Academic Centers from years 2003-2013. Fisher exact test was used to make direct comparisons between centers and treatment type. We used a Bonferroni-adjusted P.

Results: Within both the 50-59 and 60-69-year-old age groups, when compared to Academic hospitals, VAH performed surgery alone at a lower rate (87.6% vs 77.4% and 86.1% vs 77.7%, respectively) and performed Surgery + Radiation and Radiation + Hormone therapy at a significantly higher rate (8.2% vs 15.0% and 6.8% vs 10.0%, respectively). In 70-79 year age group, when compared to Academic hospitals, VAH performed surgery alone at a lower rate (73.5% vs 43.1%) and Hormone therapy only and Radiation + Hormone therapy at significantly higher rate (3.7% vs 17.3% and 20.8% vs 33.9%, respectively) (all P < .001).

Conclusion: In VAH, people within age groups of 50-59, 60-69 years had more surgery plus radiation, radiation plus HT and less surgery alone than Academic centers. In 70-79 age group, VAH performed much more HT only, radiation plus HT and less surgery alone than Academic Centers.

Recommended Reading

Lean Six Sigma Applied to Tracking Head/Neck Cancer Patients
Federal Practitioner
The Use of IVC Filters in Cancer Patients: A 15-Year Experience at a Single Veterans Affairs Medical Center
Federal Practitioner
Docetaxel-Induced Stevens-Johnson Syndrome
Federal Practitioner
Distress Screening at the Central Arkansas Veterans Healthcare System Hematology/Oncology Clinics: A Quality Improvement Project
Federal Practitioner
Evaluation of Acute Toxicities of Hypofractionated Radiotherapy Using Volumetric Arc Therapy
Federal Practitioner
Breast Cancer Screening Improvement Initiative
Federal Practitioner
Demographic and Clinical Characteristics of Patients With Polycythemia Vera (PV) in the U.S. Veterans Population
Federal Practitioner
Double-Expressor Lymphoma (DEL) in Veterans at DC VAMC
Federal Practitioner
Hematology/Oncology Ordersets: A VA VISN 09 Wide Initiative
Federal Practitioner
Big Data, Precision Oncology, and Virtual Cancer Centers: The VA’s Initiatives Transforming Cancer Care
Federal Practitioner